Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness

Elizabeth G. Raymond, Pai Lien Chen, Bosny Pierre-Louis, Joanne Luoto, Kurt T. Barnhart, Lynn Bradley, Mitchell D Creinin, Alfred Poindexter, Livia Wan, Mark Martens, Robert Schenken, Cate F. Nicholas, Richard Blackwell

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: In most recent large efficacy trials of barrier contraceptive methods, a high proportion of participants withdrew before the intended end of follow-up. The objective of this analysis was to explore characteristics of participants who failed to complete seven months of planned participation in a trial of spermicide efficacy. Methods: Trial participants were expected to use the assigned spermicide for contraception for 7 months or until pregnancy occurred. In bivariable and multivariable analyses, we assessed the associations between failure to complete the trial and 17 pre-specified baseline characteristics. In addition, among women who participated for at least 6 weeks, we evaluated the relationships between failure to complete, various features of their first 6 weeks of experience with the spermicide, and characteristics of the study centers and population. Results: Of the 1514 participants in this analysis, 635 (42%) failed to complete the study for reasons other than pregnancy. Women were significantly less likely to complete if they were younger or unmarried, had intercourse at least 8 times per month, or were enrolled at a university center or at a center that enrolled fewer than 4 participants per month. Noncompliance with study procedures in the first 6 weeks was also associated with subsequent early withdrawal, but dissatisfaction with the spermicide was not. However, many participants without these risk factors withdrew early. Conclusions: Failure to complete is a major problem in barrier method trials that seriously compromises the interpretation of results. Targeting retention efforts at women at high risk for early withdrawal is not likely to address the problem sufficiently.

Original languageEnglish (US)
Article number23
JournalBMC Medical Research Methodology
Volume4
DOIs
StatePublished - Oct 1 2004
Externally publishedYes

Fingerprint

Barrier Contraception
Pregnancy
Contraception
Population

ASJC Scopus subject areas

  • Medicine(all)
  • Health Informatics

Cite this

Raymond, E. G., Chen, P. L., Pierre-Louis, B., Luoto, J., Barnhart, K. T., Bradley, L., ... Blackwell, R. (2004). Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Medical Research Methodology, 4, [23]. https://doi.org/10.1186/1471-2288-4-23

Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. / Raymond, Elizabeth G.; Chen, Pai Lien; Pierre-Louis, Bosny; Luoto, Joanne; Barnhart, Kurt T.; Bradley, Lynn; Creinin, Mitchell D; Poindexter, Alfred; Wan, Livia; Martens, Mark; Schenken, Robert; Nicholas, Cate F.; Blackwell, Richard.

In: BMC Medical Research Methodology, Vol. 4, 23, 01.10.2004.

Research output: Contribution to journalArticle

Raymond, EG, Chen, PL, Pierre-Louis, B, Luoto, J, Barnhart, KT, Bradley, L, Creinin, MD, Poindexter, A, Wan, L, Martens, M, Schenken, R, Nicholas, CF & Blackwell, R 2004, 'Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness', BMC Medical Research Methodology, vol. 4, 23. https://doi.org/10.1186/1471-2288-4-23
Raymond, Elizabeth G. ; Chen, Pai Lien ; Pierre-Louis, Bosny ; Luoto, Joanne ; Barnhart, Kurt T. ; Bradley, Lynn ; Creinin, Mitchell D ; Poindexter, Alfred ; Wan, Livia ; Martens, Mark ; Schenken, Robert ; Nicholas, Cate F. ; Blackwell, Richard. / Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. In: BMC Medical Research Methodology. 2004 ; Vol. 4.
@article{20807e9d2122419a8d8ef9784491e165,
title = "Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness",
abstract = "Background: In most recent large efficacy trials of barrier contraceptive methods, a high proportion of participants withdrew before the intended end of follow-up. The objective of this analysis was to explore characteristics of participants who failed to complete seven months of planned participation in a trial of spermicide efficacy. Methods: Trial participants were expected to use the assigned spermicide for contraception for 7 months or until pregnancy occurred. In bivariable and multivariable analyses, we assessed the associations between failure to complete the trial and 17 pre-specified baseline characteristics. In addition, among women who participated for at least 6 weeks, we evaluated the relationships between failure to complete, various features of their first 6 weeks of experience with the spermicide, and characteristics of the study centers and population. Results: Of the 1514 participants in this analysis, 635 (42{\%}) failed to complete the study for reasons other than pregnancy. Women were significantly less likely to complete if they were younger or unmarried, had intercourse at least 8 times per month, or were enrolled at a university center or at a center that enrolled fewer than 4 participants per month. Noncompliance with study procedures in the first 6 weeks was also associated with subsequent early withdrawal, but dissatisfaction with the spermicide was not. However, many participants without these risk factors withdrew early. Conclusions: Failure to complete is a major problem in barrier method trials that seriously compromises the interpretation of results. Targeting retention efforts at women at high risk for early withdrawal is not likely to address the problem sufficiently.",
author = "Raymond, {Elizabeth G.} and Chen, {Pai Lien} and Bosny Pierre-Louis and Joanne Luoto and Barnhart, {Kurt T.} and Lynn Bradley and Creinin, {Mitchell D} and Alfred Poindexter and Livia Wan and Mark Martens and Robert Schenken and Nicholas, {Cate F.} and Richard Blackwell",
year = "2004",
month = "10",
day = "1",
doi = "10.1186/1471-2288-4-23",
language = "English (US)",
volume = "4",
journal = "BMC Medical Research Methodology",
issn = "1471-2288",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness

AU - Raymond, Elizabeth G.

AU - Chen, Pai Lien

AU - Pierre-Louis, Bosny

AU - Luoto, Joanne

AU - Barnhart, Kurt T.

AU - Bradley, Lynn

AU - Creinin, Mitchell D

AU - Poindexter, Alfred

AU - Wan, Livia

AU - Martens, Mark

AU - Schenken, Robert

AU - Nicholas, Cate F.

AU - Blackwell, Richard

PY - 2004/10/1

Y1 - 2004/10/1

N2 - Background: In most recent large efficacy trials of barrier contraceptive methods, a high proportion of participants withdrew before the intended end of follow-up. The objective of this analysis was to explore characteristics of participants who failed to complete seven months of planned participation in a trial of spermicide efficacy. Methods: Trial participants were expected to use the assigned spermicide for contraception for 7 months or until pregnancy occurred. In bivariable and multivariable analyses, we assessed the associations between failure to complete the trial and 17 pre-specified baseline characteristics. In addition, among women who participated for at least 6 weeks, we evaluated the relationships between failure to complete, various features of their first 6 weeks of experience with the spermicide, and characteristics of the study centers and population. Results: Of the 1514 participants in this analysis, 635 (42%) failed to complete the study for reasons other than pregnancy. Women were significantly less likely to complete if they were younger or unmarried, had intercourse at least 8 times per month, or were enrolled at a university center or at a center that enrolled fewer than 4 participants per month. Noncompliance with study procedures in the first 6 weeks was also associated with subsequent early withdrawal, but dissatisfaction with the spermicide was not. However, many participants without these risk factors withdrew early. Conclusions: Failure to complete is a major problem in barrier method trials that seriously compromises the interpretation of results. Targeting retention efforts at women at high risk for early withdrawal is not likely to address the problem sufficiently.

AB - Background: In most recent large efficacy trials of barrier contraceptive methods, a high proportion of participants withdrew before the intended end of follow-up. The objective of this analysis was to explore characteristics of participants who failed to complete seven months of planned participation in a trial of spermicide efficacy. Methods: Trial participants were expected to use the assigned spermicide for contraception for 7 months or until pregnancy occurred. In bivariable and multivariable analyses, we assessed the associations between failure to complete the trial and 17 pre-specified baseline characteristics. In addition, among women who participated for at least 6 weeks, we evaluated the relationships between failure to complete, various features of their first 6 weeks of experience with the spermicide, and characteristics of the study centers and population. Results: Of the 1514 participants in this analysis, 635 (42%) failed to complete the study for reasons other than pregnancy. Women were significantly less likely to complete if they were younger or unmarried, had intercourse at least 8 times per month, or were enrolled at a university center or at a center that enrolled fewer than 4 participants per month. Noncompliance with study procedures in the first 6 weeks was also associated with subsequent early withdrawal, but dissatisfaction with the spermicide was not. However, many participants without these risk factors withdrew early. Conclusions: Failure to complete is a major problem in barrier method trials that seriously compromises the interpretation of results. Targeting retention efforts at women at high risk for early withdrawal is not likely to address the problem sufficiently.

UR - http://www.scopus.com/inward/record.url?scp=8844253194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8844253194&partnerID=8YFLogxK

U2 - 10.1186/1471-2288-4-23

DO - 10.1186/1471-2288-4-23

M3 - Article

C2 - 15458571

AN - SCOPUS:8844253194

VL - 4

JO - BMC Medical Research Methodology

JF - BMC Medical Research Methodology

SN - 1471-2288

M1 - 23

ER -